Category Archives: News

Virginia Governor Glenn Youngkin recently granted clemency to former Fairfax County police sergeant Wesley Shifflett, who was convicted of reckless handling of a firearm after fatally shooting an unarmed man. Shifflett had been sentenced to three years in prison, but Youngkin called the sentence “unjust.”

Legal expert and attorney Rich Kelsey, who was featured on NPR discussing the case, supported the governor’s decision. Kelsey explained that while Shifflett was convicted of reckless handling of a firearm, he was acquitted of manslaughter, making the jail sentence unnecessary. Kelsey believes the outcome was just, given the circumstances surrounding the case.

The conviction remains in place for now, pending potential appeal.

Read full article here:
https://www.wvtf.org/news/2025-03-03/youngkin-grants-clemency-in-fairfax-officer-case-legal-experts-weigh-in

The Impresa Legal Group is proud to support the legal combination of our client IntraHealth International with the Global Communities family of companies. See

This NGO combination is slated to bring exciting potential for new growth in IntraHealth’s key areas of expertise—such as health workforce, data science, and local capacity-strengthening—but also in new areas, such as humanitarian assistance, nutrition, and climate-related health challenges. IntraHealth’s programming and expertise will allow Global Communities to expand and further integrate its international health and humanitarian assistance efforts.

Impresa supported the due diligence, compliance, and governance, as well as the corporate agreement defeminization and closing.

Impresa Legal was proud to support the definitization of a $48.3 million “OTA” contract between the Advanced Research Projects Agency for Health (ARPA-H) and our client Every Cure. See. Established in 2022 by the Biden-Harris Administration, ARPA-H is a new federal agency that aims to advance high-potential, high-impact biomedical and health research that cannot be readily accomplished through traditional research or commercial activity. Every Cure, a nonprofit on a mission to save lives by repurposing existing medicines through the development of an AI-powered platform, called ML/AI-enabled Therapeutic Repurposing In eXtended uses (MATRIX). Using MATRIX, EveryCure hopes to develop an open-source drug repurposing database that will unlock the full potential of FDA-approved drugs to treat more diseases. With ARPA-H support, Every Cure will look across all FDA-approved drugs and all diseases simultaneously and then quantify the strength of those connections to find the most promising new treatments to help patients. Impresa attorneys Jason Matechak and Jill McDowell supported Every Cure in the ARPA-H OTA negotiations.